Pulse Biosciences, Inc.
PLSE· Nasdaq
Filed Mar 20, 2017 · 10-K · 79 days after period end · 0001625101-17-000011
| Metric | Q4 2016 | Q4 2015 |
|---|---|---|
| Net Income | -$2.81M | -$1.02M |
| EPS Diluted | -$0.21 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 20, 2017 · 79 d after period end